Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,550 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

for
Relapsed or Refractory Multiple Myeloma,
Location: Duarte CA, Irvine CA, San Francisco CA, Denver CO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05652335

Phase1, Recruiting

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

for
Metastatic Sarcoma, Esophageal Cancer, Gastric Cancer,
Location: Duarte CA, Orange CA, Stanford CA, Grand Rapids MI,
Sponsor: Lantheus Medical Imaging

Sex: All

Age: 15+

Code: NCT06298916

Phase1, Phase2, Recruiting

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

for
Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma
Location: Duarte CA, Houston TX, Hackensack NJ
Sponsor: SIRPant Immunotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05967416

Phase1, Recruiting

Study of Fluconazole in Children With Autism Spectrum Disorder

for
Autism Spectrum Disorder
Location: Tarzana CA, Melbourne FL, Austin TX
Sponsor: The Center for Autism and Related Disorders

Sex: All

Age: 3 - 10

Code: NCT00936182

Recruiting

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

for
Myelofibrosis, Moderate Thrombocytopenia, Mild Thrombocytopenia
Location: Duarte CA, Salt Lake City UT, Houston TX, Cleveland OH,
Sponsor: Karyopharm Therapeutics Inc

Sex: All

Age: 18+

Code: NCT05980806

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

for
Solid Tumor, Adult Lymphoma
Location: Duarte CA, Houston TX, Pittsburgh PA
Sponsor: Cyclacel Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05358379

Phase1, Phase2, Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Duarte CA, Orange CA, Las Vegas NV, Seattle WA,
Sponsor: J-Pharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT07265674

Phase3, Recruiting

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Duarte CA, Sacramento CA, New Lenox IL, Orland Park IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05272384

Phase1, Recruiting

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

for
Cutaneous Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04670874

Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

for
Mycosis Fungoides, Non-Hodgkin's Lymphoma
Location: Duarte CA, Palo Alto CA, Salt Lake City UT, Dallas TX,
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT02848274

Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Duarte CA, Irvine CA, San Diego CA, Stanford CA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase1, Phase2, Recruiting

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Duarte CA, Houston TX, Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT03113643

Phase1, Recruiting

Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

for
Locally Advanced Unresectable Pancreatic Adenocarcinoma
Location: Duarte CA, Irvine CA
Sponsor: Impact Biotech Ltd

Sex: All

Age: 18+

Code: NCT05919238

Phase1, Recruiting

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Irvine CA, Salt Lake City UT, Seattle WA, Omaha NE,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT05477576

Phase3, Recruiting

Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06054776

Phase2, Recruiting

Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study

for
Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study,
Location: Culver City CA
Sponsor: Imugene Limited

Sex: All

Age: 18 - 70+

Code: NCT05822427

Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Duarte CA, Salt Lake City UT, Denver CO, Houston TX,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase1, Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Duarte CA, San Diego CA, San Francisco CA, Seattle WA,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase1, Phase2, Recruiting

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Duarte CA, Orange CA, Irvine CA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04172532

Phase1, Phase2, Recruiting

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

for
Metastatic Breast Cancer
Location: Duarte CA
Sponsor: Minerva Biotechnologies Corporation

Sex: All

Age: 18+

Code: NCT04020575

Phase1, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles